# First in Human Study to Assess Safety and Efficacy of an Implantable Nitinol Device in the Treatment of Keratoconus

> **NCT06451718** · NA · RECRUITING · sponsor: **Recornea Srl** · enrollment: 12 (estimated)

## Conditions studied

- Keratoconus

## Interventions

- **DEVICE:** Nitinol net for intracorneal implant for keratoconus treatment

## Key facts

- **NCT ID:** NCT06451718
- **Lead sponsor:** Recornea Srl
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-03
- **Primary completion:** 2027-02
- **Final completion:** 2027-02
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06451718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06451718, "First in Human Study to Assess Safety and Efficacy of an Implantable Nitinol Device in the Treatment of Keratoconus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06451718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*